[Federal Register Volume 85, Number 89 (Thursday, May 7, 2020)]
[Notices]
[Pages 27248-27249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09707]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-641]
Importer of Controlled Substances Application: AndersonBrecon
Inc. dba PCI of Illinois
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 8, 2020.
Such persons may also file a written request for a hearing on the
application on or before June 8, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 20, 2020, AndersonBrecon Inc. dba PCI of
Illinois, 5775 Logistics Parkway, Rockford, Illinois 61109-3608,
applied to be registered as an importer of the following basic
class(es) of a controlled substance:
[[Page 27249]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols................. 7370 I
------------------------------------------------------------------------
The company plans to import the listed controlled substance for
clinical trial only. Approval of permit applications will occur only
when the registrant's business activity is consistent with what is
authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to
the import of Food and Drug Administration-approved or non-approved
finished dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-09707 Filed 5-6-20; 8:45 am]
BILLING CODE 4410-09-P